Kevin M. Byrne - Concepedia

Author

Kevin M. Byrne

MSD (Spain)

Also Known As

K. BYRNE, K. Byrne, K. M. BYRNE, K.M. Byrne, KEVIN M. BYRNE, Kevin Byrne, Kevin M. Byrne

Publications

986

Citations

H-Index

Concepts

All Affiliations

MSD (Spain)Merck & Co., Inc., Rahway, NJ, USA (United States)Cancer Research Center Rutgers, The State University of New Jersey

About

Kevin M. Byrne is an author at MSD (Spain) specializing in microbiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	324
2	Biochemistry	8	8	271
3	Natural Sciences	6	6	205
4	Biomolecular Engineering	3	3	74
5	Engineering	2	2	67

Kevin M. Byrne

Publications

827

Citations

H-Index

Page 1

	Year	Citations
Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties. Ramesh C. Pandey, Margaret W. Toussaint, Ronald M. Stroshane, The Journal of Antibiotics	1981	109
Biosynthesis of Nodulisporic Acid A: Precursor Studies Kevin M. Byrne, Scott K. Smith, John G. Ondeyka Journal of the American Chemical Society	2002	65
Fredericamycin A a new antitumor antibiotic. II. Biological properties. DANA J. WARNICK-PICKLE, Kevin M. Byrne, Ramesh C. Pandey, The Journal of Antibiotics	1981	61
Studies on the mechanism of action of gilvocarcin V and chrysomycin A. Tena Wei, Kevin M. Byrne, DANA WARNICK-PICKLE, The Journal of Antibiotics Medicinal ChemistryAntifungal AgentBioorganic ChemistryAntibioticsBiochemistry	1982	55
Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation Jennifer Nielsen, Ming Jo Hsu, Kevin M. Byrne, Biochemistry	1991	43
Coniothyrione, a Chlorocyclopentandienylbenzopyrone as a Bacterial Protein Synthesis Inhibitor Discovered by Antisense Technology John G. Ondeyka, Deborah L. Zink, Ángela Basilio, Journal of Natural Products Bioorganic ChemistryAntiparasitic AgentEscherichia ColiAntisense TechnologyAntimicrobial Chemotherapy	2007	42
Biosynthesis of fredericamycin A, a new antitumor antibiotic Kevin M. Byrne, Bruce D. Hilton, Richard White, Biochemistry	1985	38
Distribution of zaragozic acids (squalestatins) among filamentous ascomycetes Gerald F. Bills, Fernando Peláez, Jon D. Polishook, Mycological Research Industrial MycologyBiosynthesisMicrobiologyZaragozic Acids	1994	37
Isolation, Structure, and Antibacterial Activities of Lucensimycins D−G, Discovered from <i>Streptomyces lucensis</i> MA7349 Using an Antisense Strategy Sheo B. Singh, Deborah L. Zink, Karen Dorso, Journal of Natural Products Antimicrobial Drug DiscoveryAntimicrobial SusceptibilityBiochemistryAntibioticsLucensimycins D	2008	35
Use of soybean oil and ammonium sulfate additions to optimize secondary metabolite production Beth Junker, Zorina Mann, P. Gailliot, Biotechnology and Bioengineering EngineeringAgricultural EconomicsSecondary MetaboliteM3 Fermentation ScaleValine-overproducing Mutant	1998	35

Page 1